Clinical Trials Directory

Trials / Unknown

UnknownNCT05022875

Effectiveness of The Health Care CEO App for T1D

Effectiveness of the 'Healthcare CEO' App for Type 1 Diabetes Patients Transitioning From Adolescence to Early Adulthood: Protocol for a Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
96 (estimated)
Sponsor
Chang Gung University · Academic / Other
Sex
All
Age
16 Years – 25 Years
Healthy volunteers
Not accepted

Summary

The present study aims to evaluate the intervention effectiveness of the Healthcare Chief Executive Officer mobile application(Healthcare CEO app) in patients with type 1 diabetes transitioning from adolescence to early adulthood.

Detailed description

Aim:The present study aims to evaluate the intervention effectiveness of the Healthcare Chief Executive Officer mobile application in patients with type 1 diabetes transitioning from adolescence to early adulthood. Design: A 9-month two-arm, parallel-group, single-blind, randomized controlled trial Methods: Ninety-six Type-1 diabetes patients, aged 16-25 years, are expected to participate in this study. Participants will be randomly assigned to the experimental or control group by central randomization. The Healthcare Chief Executive Officer app, which consists of the following functions: data recording, knowledge, communication skills, food swap guide, exercise recommendations, chatroom, reminders, and SOS, will be used as the intervention measure. We will compare the differences in disease control outcomes, confidence in self-management, self-care behaviors, emotional distress, quality of life, and specific diabetes-related knowledge between the two groups before intervention and at 3, 6, and, 9 months post-intervention. The differences within the experimental group pre- and post- intervention will also be analyzed. This study design was approved by the ethics committee of the researcher's affiliation in March 2021.

Conditions

Interventions

TypeNameDescription
DEVICEHealthcare CEO app- for experimental app interventionThe app content was designed based on the results of previous qualitative and Delphi studies (Chiang et al., 2021; Chiang et al., 2020) and consists of 11 interfaces: CEO's profile, Health Tracking, CEO Knowledge Base, Barrier-free Communication, See Here: Diet and Exercise, Help Me, Detective!, CEO Chatroom, CEO's Secretary, Who's the Best CEO, SOS Calls, and Q\&A
DEVICEHealthcare CEO app-for control app interventionconsists of 2 interfaces: CEO's profile, Health Tracking.

Timeline

Start date
2021-04-23
Primary completion
2022-07-31
Completion
2022-07-31
First posted
2021-08-26
Last updated
2021-08-26

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05022875. Inclusion in this directory is not an endorsement.

Effectiveness of The Health Care CEO App for T1D (NCT05022875) · Clinical Trials Directory